Format

Send to

Choose Destination
Australas Radiol. 2007 Dec;51 Suppl:B299-302. doi: 10.1111/j.1440-1673.2007.01802.x.

Fluoromethylcholine PET in recurrent multifocal hepatoma.

Author information

1
WA PET/Cyclotron Service, Sir Charles Gairdner Hospital, Perth, Australia. nlenzo@mac.com

Abstract

F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has variable efficacy in evaluating hepatocellular carcinoma. We present a case of a new oncologic imaging tracer fluoromethylcholine (FCH), which has visualized recurrent multifocal hepatoma in a patient with a poor FDG avid hepatic tumour. The lesions demonstrated on FCH PET correlated well with the findings on CT hepatic angiography.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center